Wiener Neudorf, Austria

Angela Siegling

USPTO Granted Patents = 5 



Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Paris, FR (2003 - 2004)
  • Brunn am Gebirge, AT (2013)
  • Wiener Neudorf, AT (2014 - 2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Angela Siegling: Innovator in Viral Genome Research

Introduction

Angela Siegling is a prominent inventor based in Wiener Neudorf, Austria. She has made significant contributions to the field of viral genome research, holding a total of 5 patents. Her work focuses on recombinant proteins and their applications in pharmaceutical compositions.

Latest Patents

One of her latest patents involves recombinant proteins of parapoxvirus ovis and pharmaceutical compositions derived from them. This invention relates to polynucleotides coding for the PPVO viral genome, including fragments of these polynucleotides and polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also encompasses recombinant proteins expressed from these polynucleotides and their fragments, as well as their use in preparing pharmaceutical compositions.

Career Highlights

Angela has worked with notable companies such as Aicuris GmbH & Co. KG and Bayer Aktiengesellschaft. Her experience in these organizations has contributed to her expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Angela has collaborated with professionals like Olaf Weber and Tobias Schlapp, enhancing her research and development efforts in viral genome studies.

Conclusion

Angela Siegling is a dedicated inventor whose work in viral genome research has led to significant advancements in the field. Her contributions continue to impact the development of pharmaceutical compositions, showcasing her commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…